The Venture Codex Logo

The Venture Codex

AJU IB Investment

201, Teheran-ro, Seoul, Gangnam-gu, 06141, South Korea

Overview

Aju IB Investment is a venture capital firm that offers SMEs with investments and consulting services. Aju IB Investment offers consulting services that focus on business management, tax, accounting, legal, mergers and acquisitions, additional funding, marketing, and technology support. Aju IB Investment was founded in September 1974 and is based in Seoul, South Korea.

Total investments
26
Lead investments
4
Investments · 12mo
1
Active investors
4

Sector focus

  • Finance
  • Financial Services
  • Venture Capital
Visit website

Investment portfolio

  • Nventric

    Participated · Equity · Jun 2026

    Enventric develops vascular medical devices for cerebral infarction treatment, with approved products including the EvoGlide distal access catheter and the ULTRIVA stent retriever. The company reported cumulative revenue of about 6 billion won over the past four years and a compound annual growth rate of 52.9% over that period. Enventric is accelerating R&D and expanding manufacturing capacity following recent regulatory approvals. It is pursuing global market entry and has begun formal IPO preparations on KOSDAQ, appointing Kiwoom Securities as its underwriter. The recent 34.5 billion won pre-IPO equity raise broadens its institutional investor base and includes follow-on participation from several existing investors. Management has stated the capital will be used to bolster R&D, scale manufacturing, and support the company’s listing and international expansion efforts.

  • Illimis Therapeutics

    Participated · Series B · Jul 2025

    Illimis Therapeutics develops therapies for central nervous system and immune disorders using its proprietary GAIA (Gas6-mediated Anti-Inflammatory Adaptor) platform. The company's lead program, ILM01 for Alzheimer's Disease, is entering preclinical development in the second half of 2025 with an IND targeted by the end of 2027. Proceeds from the recent financing will accelerate GAIA-based Alzheimer's programs, expand target indications into various immune disorders, and broaden its pipeline toward potential blockbuster candidates. Illimis is pursuing early-stage co-development with global pharmaceutical companies and research institutions and has established collaborations including Eli Lilly's Catalyze360-ExploR&D, participation in BMS Innovation Square Challenge, and membership in JLABS Singapore. A Scientific Advisory Board that includes Dr. Greg Lemke and Dr. Morgan Sheng provides strategic guidance across R&D, candidate discovery, and clinical trial design. The company was selected for the '2025 Global Joint Research to Defeat Dementia' and secured KRW 2.2 million ($1.6 million) in funding over three years to support international Alzheimer's research efforts.

  • bitsensing

    Participated · Series B · Jun 2024

    Bitsensing develops high-resolution 4D imaging radar systems for autonomous vehicles and adjacent markets such as smart cities and digital health. Its core products include surround-detection automotive radars with range coverage of more than 300 meters and a claimed 50% improvement in detection range versus conventional radar. The company also offers TIMOS, a traffic insight monitoring sensor that integrates edge AI (powered by an Nvidia Jetson GPU) to fuse camera and radar data for traffic management; TIMOS is deployed across six countries and provides visibility across 12 lanes of traffic. Bitsensing is pursuing additional commercial applications including sleep-care monitoring for apnea and limb movements and provides APIs for integration into senior care facilities and hospitals. The startup says it is in a revenue-growth stage and aims to expand globally via strategic partnerships, hardware and software sales, data, and licensing contracts. Bitsensing was founded in 2018 in South Korea and has raised $46 million in total to date. bitsensing develops 4D imaging radar technology and sensor-fusion AI solutions intended to enable smart cities and connected living. The company builds radar solutions across business areas and has introduced a wellness solution that provides sleep analysis, lifestyle recommendations, and early-stage illness prediction from accumulated sleep data. Led by CEO Dr. Jae‑Eun Lee, bitsensing combines imaging radar hardware with software and AI to deliver sensing and analytics services. The company raised $10M in a Series A to advance its radar solutions and services. It plans to use the funds to expand its business and enter global markets. bitsensing is based in Seoul, South Korea. Bitsensing develops radar-based sensing technology that leverages radar sensors to detect targets and track and map activity in real time without creating privacy issues and while maintaining performance in harsh weather. The company's sensors are positioned for use across automotive, smart home, robotics and autonomous driving applications. Led by CEO Jae-eun Lee, Bitsensing has joined programs and partnerships including NVIDIA Inception, an Infineon partnership, Plug and Play Japan for Mobility and Plug and Play Thailand for Smart Cities. The startup intends to use its latest funding to further enhance its technology, expand offerings in key industries and grow its global presence and partnerships. Financially, Bitsensing had previously raised $1.2M in seed rounds and reports total equity financing of $7.0M following the new round. The company is based in Seoul, South Korea.

  • MEZOO

    Participated · Series B · Nov 2023

    Meju develops HiCardi, a remote patient real-time monitoring platform used for continuous vital-sign tracking. The company has commercial partnerships including a domestic distribution agreement with 동아ST and a memorandum with HL만도 to develop Digital Healthcare Automotive solutions. Meju is expanding HiCardi beyond healthcare into industrial safety monitoring for construction and factory workers and is in final negotiations with a Korean public enterprise for product supply. Financially, Meju reported approximately ₩1.4bn in revenue in 2022, is targeting ₩4.0bn in 2023, and aims for ₩10.0bn in revenue by 2025 to reach breakeven. Its investors have cited the company’s technology, commercialization progress, and growth potential when committing capital.

  • Laundrygo

    Participated · Series C · Nov 2022

    Laundrygo operates an on-demand mobile app that enables customers to schedule pickup and delivery of laundry and dry cleaning within 24 hours and also runs laundromats and smart factories to handle washing and drying. The company offers three primary businesses: consumer pickup/delivery (Laundrygo), B2B laundry for hotels (Laundrygo Business) and laundromats (Laundry24), plus an alterations service (LaundryX). Laundrygo has built an AI-powered laundry screening system that automatically sorts items and performs all cleaning in-house using its smart factory, and it says it uses an environmentally friendly detergent. The startup has grown rapidly: it reported 4.4 billion won (~$3.3M) in sales in October, said sales are more than 20x versus a year earlier, has more than 130,000 registered users and employs over 500 people, and has tripled annual sales since 2021. Laundrygo has pursued acquisitions (including U.S.-based A+ Machinery) to enter the smart factory business and says it will continue acquiring businesses that create synergies. The company plans to invest in its smart factory technology and expand the laundromat business, with intentions to open a Laundry24 in New York as early as next year and to consider expansion into Japan.

Team

  • Jiwon Kim

    CEO

    LinkedIn
  • Jeong Moo-il

    Team manager

  • Derek Yoon

    Partner

    LinkedIn
  • Yoon Chang-soo

    General Manager